| 000 | 01487nam a22002177a 4500 | ||
|---|---|---|---|
| 005 | 20260415090506.0 | ||
| 008 | 240113b |||||||| |||| 00| 0 eng d | ||
| 020 | _a9780857114419 | ||
| 050 |
_aAllied KJE 6201.A15 _bR85 2022 |
||
| 245 |
_aRules and guidance for pharmaceutical distributors 2022 / _cMedicines & Healthcare products Regulatory Agency |
||
| 264 |
_aU.K : _bPharmaceutical Press , _c2022. |
||
| 300 |
_axvii, 377 pages : _c24 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 500 | _aIncludes index. | ||
| 505 | _aMedicines and healthcare products regulatory agency -- Wholesale distribution of medicines ; 2. UK legislation on wholesale distribution ; 3. EU guidelines on GDP and UK guidance on wholesale distribution -- Brokering of Medicines ; 4. UK legislation on brokering medicines ; 5. EU guidelines on GDP and UK guidance on brokering medicines -- Manufacture, importation and distribution of active substances ; 6. UK legislation on the manufacture, importation and distribution of active substances ; 7. Guidelines of 19 March 2015 on principles of good distribution practice of active substances for medicinal products for human use (2015/C 95/01) ; 8. UK guidance on the manufacture, importation and distribution of active substances. | ||
| 650 |
_aDrugs _xLaw and legislation _zGreat Britain |
||
| 650 |
_aDrugs _xmarketing -Law & Legislation _zGreat Britain |
||
| 942 |
_2lcc _cBK _kEAC Cavite-Allied |
||
| 999 |
_c94447 _d94447 |
||